New member: Hemispherian
Our newest member Hemispherian is developing a better treatment option for patients with aggressive brain cancer.
Sofia Lindén is responsible for producing the content for digital communications in the cluster, including articles, photographs and videos for the websites and social media platforms.
She has previously worked at the Nordic publishing company Orage as Swedish Print Editor and Digital Project Manager. She also holds a master degree in International Journalism from City University London. Find out more about Sofia by visiting her LinkedIn.
Our newest member Hemispherian is developing a better treatment option for patients with aggressive brain cancer.
Targovax releases 12-month data from clinical trial
The 9th International Cancer Cluster Showcase is live until 8 July 2020.
A Norwegian technology uses ultrasound to enhance the effect of chemotherapy
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.